MOLNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

MOLECULAR PARTNERS AG

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 12, 2026

$3.66+0.10 (+2.81%)

Close on Oct 19, 2026

MOLECULAR PARTNERS AG balance sheet

Annual Quarterly

CHF USD

Millions of CHF, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31
Cash & Equivalents	83	64	67	88	72	134	76	99
Cash & Short-Term Investments	83	64	67	88	72	134	76	99
Receivables	1.83	2.32	1.95	1.02	26	2.84	–	–
Other Current Assets	1.99	2.53	3.62	4.59	5.73	–	–	–
Total Current Assets	97	154	192	255	164	178	–	–
Property, Plant & Equipment	–	–	–	7.24	8.15	9.39	–	–
Intangible Assets	0.00	0.05	0.21	0.27	0.33	0.35	–	–
Total Assets	102	159	198	262	173	188	–	–
Accounts Payable	1.77	1.86	1.33	2.14	7.39	5.83	–	–
Current Portion of Leases	1.21	1.22	1.21	1.20	1.19	1.18	–	–
Other Current Liabilities	0.46	0.58	0.71	0.57	0.56	0.78	–	–
Total Current Liabilities	11	11	14	17	47	58	–	–
Long-Term Leases	2.44	1.23	2.44	3.65	4.85	6.04	–	–
Operating Lease Liabilities	3.64	2.44	3.65	4.85	6.04	7.22	2.55	–
Total Liabilities	22	17	22	27	65	80	–	–
Common Stock	4.04	4.04	3.64	3.60	3.23	2.92	–	–
Retained Earnings	-312	-246	-192	-128	-251	-195	–	–
Treasury Stock	-1.13	-0.98	-0.98	-0.98	0	–	–	–
Total Equity	80	142	176	235	107	107	54	92
Total Liabilities & Equity	102	159	198	262	173	188	–	–
Shares Outstanding(shares)	40	40	36	36	32	29	22	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: –

Financial strength

Current ratio: 7.27
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 691.8%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –

Valuation ratios need the share price and fill in once daily prices are connected.